Scientists and pharmaceutical companies alike are finally nearing the ending stages of preparing a vaccine for COVID-19 for commercial use. With at least 10 vaccine candidates currently in the early phases of human testing and two candidates likely to receive FDA authorization in the coming weeks, governments and citizens worldwide are eager to begin the end of the ongoing pandemic.